KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,207,332 | -4.8% | 760,353 | -22.8% | 0.16% | +5.9% |
| Q2 2023 | $13,871,560 | +45.4% | 985,196 | +11.1% | 0.15% | +40.7% |
| Q1 2023 | $9,542,721 | -11.2% | 886,870 | +23.7% | 0.11% | -15.6% |
| Q4 2022 | $10,743,222 | -9.8% | 717,171 | -22.7% | 0.13% | -12.3% |
| Q3 2022 | $11,917,000 | +6.8% | 928,094 | -19.4% | 0.15% | +14.1% |
| Q2 2022 | $11,155,000 | -15.0% | 1,151,137 | -12.9% | 0.13% | +11.3% |
| Q1 2022 | $13,131,000 | -12.4% | 1,320,977 | +3.8% | 0.12% | -4.2% |
| Q4 2021 | $14,984,000 | +6.5% | 1,273,049 | +3.1% | 0.12% | +9.1% |
| Q3 2021 | $14,063,000 | +17.4% | 1,234,650 | +43.6% | 0.11% | +22.2% |
| Q2 2021 | $11,978,000 | -25.7% | 859,874 | -1.2% | 0.09% | -25.0% |
| Q1 2021 | $16,112,000 | -21.1% | 870,422 | -24.7% | 0.12% | -24.1% |
| Q4 2020 | $20,432,000 | +15.0% | 1,156,338 | -0.3% | 0.16% | -6.5% |
| Q3 2020 | $17,760,000 | -10.0% | 1,159,301 | -9.0% | 0.17% | -34.7% |
| Q1 2020 | $19,728,000 | -21.9% | 1,274,424 | -44.2% | 0.26% | +15.1% |
| Q4 2019 | $25,257,000 | +45.1% | 2,283,661 | +11.6% | 0.22% | +29.3% |
| Q3 2019 | $17,407,000 | -27.9% | 2,045,508 | +14.7% | 0.17% | -25.0% |
| Q2 2019 | $24,154,000 | -16.9% | 1,783,884 | +10.8% | 0.23% | -15.3% |
| Q1 2019 | $29,080,000 | -16.3% | 1,610,181 | +30.2% | 0.27% | -24.9% |
| Q4 2018 | $34,741,000 | +31.1% | 1,236,770 | +3.7% | 0.36% | +64.4% |
| Q3 2018 | $26,494,000 | +915.9% | 1,192,424 | +693.2% | 0.22% | +825.0% |
| Q2 2018 | $2,608,000 | – | 150,331 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |